Acciones Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Acciones
TEVA
IL0006290147
Farmacéuticos
Ventas 2024 * | 15,86 mil M 58,89 mil M 14,74 mil M | Ventas 2025 * | 16,4 mil M 60,89 mil M 15,24 mil M | Capitalización | 15,83 mil M 58,8 mil M 14,72 mil M |
---|---|---|---|---|---|
Resultado Neto 2024 * | 1538 M 5711,67 M 1429,54 M | Resultado Neto 2025 * | 1442 M 5355,16 M 1340,31 M | VE / Ventas 2024 * | 1,93 x |
Deuda neta 2024 * | 14,82 mil M 55,02 mil M 13,77 mil M | Deuda neta 2025 * | 12,25 mil M 45,49 mil M 11,38 mil M | VE / Ventas 2025 * | 1,71 x |
P/E ratio 2024 * |
11,2
x | P/E ratio 2025 * |
10,5
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 89,71 % |
Último transcript sobre Teva Pharmaceutical Industries Limited
Directores | Puesto | Edad | Desde |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/09/15 |
Janet Vergis
BRD | Director/Board Member | 60 | 09/06/20 |
Sol Barer
CHM | Chairman | 76 | 01/01/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+26,08 % | 662 mil M | |
+21,85 % | 546 mil M | |
-4,77 % | 359 mil M | |
+16,97 % | 323 mil M | |
+5,69 % | 290 mil M | |
+13,68 % | 234 mil M | |
+3,65 % | 198 mil M | |
-11,12 % | 194 mil M | |
+8,08 % | 167 mil M |